资讯

With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...
The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...
Around 1,000 of these jobs will be within the company with the others in supporting roles, including construction. The ...
Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...
Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...
Meanwhile, Asian markets, South Korea's Kospi index, Tokyo's Nikkei 225, Shanghai SSE Composite and Hong Kong's Hang Seng ...
We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going ...
Investing.com — Alliance Pharma plc已披露,其董事Richard McKenzie计划于2025年4月24日或之后收购公司23,000股股份,占股份总数的0.004%。此举紧随2025年1月10日宣布的Aegros Bidco Limited对Alliance的收购建议,Aegros Bidco Limited将由DBAY Advisors ...
这一变化发生在同一天,此前该公司于6月7日披露的配股增加了公司已发行股本。根据向伦敦证券交易所提交的监管文件,Theobald在N4 Pharma PLC的直接投票权现对应16,981,319股股份。
Asian markets, South Korea's Kospi index, Tokyo's Nikkei 225, Shanghai SSE Composite and Hong Kong's Hang Seng were trading ...
Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people with overweight or ...